Properties of PAF-synthesizing phosphocholinetransferase and evidence for lysoPAF acetyltransferase activity in rat brain
- 1 December 1991
- Vol. 26 (12) , 986-991
- https://doi.org/10.1007/bf02536489
Abstract
Several reports have indicated that platelet-activating factor (PAF) may play a role in the physiopathology of nervous tissue. We previously have demonstrated the presence, in the microsomal fractions of rat brain, of a phosphocholinetransferase which is able to synthesize PAF by thede novo pathway. The presence of dithiothreitol in the medium increases the rate of PAF biosynthesis, whereas it inhibits the synthesis of long-chain alkylacyl- and diacyl-glycerophosphocholines (GPC), including dioctanoyl-GPC. This and other properties, such as pH dependence and thermal stability, indicate that rat brain may have two distinct enzymes for the synthesis of PAF and other choline phospholipids. The affinity of these enzymes for CDPcholine is similar to that reported for other tissues, the Km being 42 μm and 55 μm with alkylacetylglycerol and dioctanoylglycerol as lipid substrates, respectively. The Vmax values were 3.0 and 2.2 nmol/mg prot/min for PAF and dioctanoyl-GPC, respectively. In addition, it was shown that the microsomal fraction of rat brain contains an acetyltransferase which can convert lysoPAF to PAF. Since it has been reported previously that brain tissue possesses phospholipase A2 activity that can hydrolyze alkylacyl-GPC to lysoPAF, we conclude that brain tissue has all enzymic activities for the synthesis of PAF by the “remodeling pathway”. The role of the two routes of PAF biosynthesis in nervous tissue remains to be established.Keywords
This publication has 23 references indexed in Scilit:
- The de novo biosynthesis of Platelet-Activating Factor in rat brainBiochemical and Biophysical Research Communications, 1989
- Production and effects of platelet-activating factor in the rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Neuroregulatory and Neuropathological Actions of the Ether-Phospholipid Platelet-Activating FactorScience, 1988
- Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injuryBiochemical and Biophysical Research Communications, 1987
- Quantitative Analysis of Alkylacyl, Alkenylacyl, and Diacyl Types of Diglycerides Obtained from GlycerophospholipidsJournal of Liquid Chromatography, 1987
- Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brainBiochemical and Biophysical Research Communications, 1987
- Platelet-Activating Factor and Related Lipid MediatorsPublished by Springer Nature ,1987
- A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterization of 1-alkyl-2-lyso-sn-glycero-3-P:acetyl-CoA acetyltransferase in rat spleen.Published by Elsevier ,1986
- Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissuesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959